News
Health equity should start at birth
Medcitynews in 2022 reports that pregnant women and others able to give birth are ...
Press Release
Aetion Welcomes Chief Product Officer
Aetion is pleased to announce the appointment of Priya Bhargava as Chief Product Officer. ...
Press Release
Replica Analytics’ new estimator uses synthetic data for more reliable evaluation of re-identification risk in datasets
OTTAWA, July 19, 2022 — Replica Analytics, an Aetion company, has unveiled a novel ...
Press Release
C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research
NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and ...
Press Release
EY Announces Carolyn Magill and Dr. Jeremy Rassen of Aetion as Entrepreneur Of The Year® 2022 New York Award Finalists
NEW YORK, NEW YORK | Ernst & Young LLP (EY US) today announced that CEO and Board ...
Press Release
National Evaluation System for health Technology Coordinating Center (NESTcc) Partners with Aetion to Transform the Role of RWE for Medical Devices
ARLINGTON, Va. and NEW YORK, April 21, 2022 /PRNewswire/ -- Today, the National ...
Press Release
Cognito Therapeutics and Aetion announce partnership to use artificial intelligence to identify rapidly progressing forms of mild cognitive impairment and Alzheimer's disease
CAMBRIDGE, Mass. & NEW YORK--( BUSINESS WIRE)-- Cognito Therapeutics, a pioneer in ...
News
Using real-world evidence to advance COVID-19 medical countermeasures
The project focuses on rapidly assessing the safety and effectiveness of COVID-19 ...
News
Aetion acquires Replica Analytics to bring aboard synthetic data capabilities
Health analytics firm Aetion has acquired Replica Analytics, a company that specializes ...
News
Real-world evidence firm Aetion grabs privacy-protected synthetic data provider Replica Analytics
Aetion, which provides real-world evidence and analytics to drug companies, payers, life ...
News
Aetion snaps up AI health data specialist Replica Analytics
Aetion's acquisition of artificial intelligence data specialist Replica Analytics gives ...
News
Aetion acquires synthetic data platform Replica Analytics
This acquisition allows Aetion to solve for one of the toughest problems in RWE: access ...
News
Aetion snaps up synthetic real-world data company Replica Analytics
Less than a year after Aetion landed $110 Million in Series C funding, Aetion acquires ...
Press Release
Aetion acquires synthetic data trailblazer Replica Analytics
NEW YORK, NY and OTTAWA, ON, January 4, 2022 — Aetion, the leading regulatory-grade ...
Press Release
Replica Analytics Acquired by Aetion
Today, Replica Analytics announced that it had been acquired by healthcare analytics ...
Press Release
European Medicines Agency selects Aetion to support safety and efficacy research in Europe
BARCELONA, SPAIN, December 1, 2021 — The European Medicines Agency (EMA) has selected ...
News
FDA, Aetion expand RWE work to focus on inpatient COVID-19 therapies
FDA and Aetion announced they will use the Aetion Evidence Platform® to gather real-world ...
News
How to collect and submit RWD to win approval for a new drug indication: FDA spells it out in a long-awaited guidance
EndPoints News reports in 2021 that real-world data are messy. There can be differences ...
News
FDA contracts Aetion’s real-world evidence platform to assess COVID-19 treatments
The Food and Drug Administration has contracted with real-world evidence company Aetion ...
News
Real-world evidence: 'Labor-intensive' data standardization may be required by US FDA
New draft guidance offers recommendations for translating real-world data from claims or ...
Press Release
Aetion FDA | FDA selects Aetion Evidence Platform® to advance regulatory science and innovation
NEW YORK, NY, October 21, 2021 — Today, Aetion announces that it is expanding its ...
News
Heard at HLTH: Can we get Ironman’s J.A.R.V.I.S. in the world of drug development?
MedCity News 2021 writes that at the recent HLTH conference, a panel discussed the role ...
News
FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) ...
News
England’s NICE starts work to develop RWE standards
NICE collaborates with Aetion to leverage real-world evidence studies to address evidence ...